| Literature DB >> 30649698 |
Bustanul Arifin1,2,3, Lusiana Rusdi Idrus4,5,6, Antoinette D I van Asselt4,5,7, Fredrick Dermawan Purba8,9, Dyah Aryani Perwitasari10, Jarir At Thobari11, Qi Cao4, Paul F M Krabbe7, Maarten J Postma4,5,12,7,13,14.
Abstract
OBJECTIVES: To present EuroQol-5D (EQ-5D) index scores in Indonesian type 2 diabetes mellitus (T2DM) outpatients and to investigate the associations between EQ-5D and socio-demographic characteristics and clinical condition.Entities:
Keywords: EQ-5D-5L; Health-related quality of life; Index scores; Indonesia; Type 2 diabetes mellitus
Mesh:
Year: 2019 PMID: 30649698 PMCID: PMC6470109 DOI: 10.1007/s11136-019-02105-z
Source DB: PubMed Journal: Qual Life Res ISSN: 0962-9343 Impact factor: 4.147
Distribution of participants within different subgroups over reporting problems (slight to extreme problems) on the EQ-5D dimensions and mean (95% CI) EQ-5D index score according to socio-demographic characteristics and clinical condition in Indonesian T2DM outpatients using the Indonesian EQ-5D tariff
| Characteristics | % reporting problems | EQ-5D index score (95% CI) | |||||
|---|---|---|---|---|---|---|---|
| Mobility | Self-care | Usual activities | Pain/discomfort | Anxiety/depression | |||
| Total participants | 907 (100) | 37 | 12 | 23 | 61 | 34 | 0.77 (0.75–0.79) |
| Socio-demographic characteristics | |||||||
| Region | |||||||
| Java | 499 (55) | 38 | 13 | 23 | 57 | 36 | 0.78 (0.75–0.80) |
| Sulawesi | 408 (45) | 37 | 12 | 23 | 65 | 33 | 0.76 (0.73–0.79) |
| Sex | |||||||
| Male | 387 (43) | 34 | 11 | 22 | 58 | 37 | 0.79 (0.75–0.81)* |
| Female | 520 (57) | 40 | 14 | 24 | 63 | 37 | 0.76 (0.73–0.78) |
| Age (59.32 ± 9.70) | 886 (98)# | ||||||
| Productive age (< 56 years) | 289 (32) | 32* | 12 | 25 | 61 | 43** | 0.77 (0.73–0.80) |
| Retirement age (≥ 56 years) | 597 (66) | 40 | 12 | 22 | 60 | 30 | 0.77 (0.75–0.80) |
| Occupation | |||||||
| Active employment | 314 (35) | 30** | 8** | 19** | 59* | 33** | 0.81 (0.78–0.84)** |
| Unemployed | 234 (26) | 36 | 11 | 19 | 56 | 27 | 0.79 (0.75–0.82) |
| Housewife | 359 (39) | 45 | 17 | 30 | 66 | 41 | 0.72 (0.69 − 0.075) |
| Education | |||||||
| Up to senior high school | 698 (77) | 41** | 15** | 27** | 65** | 37** | 0.74 (0.72–0.76)** |
| University degree | 209 (23) | 24 | 4 | 12 | 48 | 27 | 0.86 (0.83–0.89) |
| Level of health facilities | |||||||
| Primary care | 133 (15) | 20** | 3** | 8** | 40** | 41 | 0.90 (0.87–0.92)** |
| Secondary care | 774 (85) | 40 | 14 | 26 | 64 | 33 | 0.74 (0.73–0.77) |
| Dependency on a caregiver | |||||||
| Yes | 488 (54) | 44** | 15** | 27** | 64* | 37 | 0.72 (0.69–0.75)** |
| No | 419 (46) | 29 | 9 | 19 | 57 | 32 | 0.83 (0.81–0.85) |
| Clinical condition | |||||||
| T2DM durationa | 805 (89)# | ||||||
| < 5 years | 446 (49) | 38 | 15 | 29** | 63 | 36 | 0.76 (0.74–0.79) |
| ≥ 5 years | 359 (40) | 43 | 12 | 20 | 64 | 32 | 0.74 (0.71–0.77) |
| Therapy | |||||||
| None (diet, herbal or exercise)b | 49 (5) | 47** | 27** | 41** | 59* | 45 | 0.61 (0.47–0.76)** |
| OAD (mono and combinations) | 490 (55) | 32 | 10 | 19 | 57 | 32 | 0.81 (0.79–0.83) |
| Insulin (mono and combination with OAD) | 368 (40) | 44 | 14 | 27 | 66 | 37 | 0.74 (0.71–0.77) |
| Types of complications and comorbidities | |||||||
| Complications | |||||||
| None | 269 (30) | 33 | 8** | 14** | 57 | 33 | 0.80 (0.76–0.83)* |
| Macrovascular | 290 (32) | 38 | 11 | 23 | 59 | 33 | 0.79 (0.72–0.82) |
| Microvascular | 140 (15) | 36 | 11 | 21 | 64 | 29 | 0.77 (0.72–0.82) |
| Macro and microvascular | 30 (3) | 47 | 23 | 44 | 56 | 34 | 0.69 (0.56–0.80) |
| Comorbiditiesc | 86 (10) | 36 | 20 | 36 | 69 | 44 | 0.71 (0.65–0.78) |
| Comorbidities + T2DM complications | 92 (10) | 49 | 22 | 36 | 67 | 42 | 0.70 (0.63–0.76) |
| Number of T2DM complications | |||||||
| None | 269 (30) | 33* | 8* | 14** | 57 | 33 | 0.80 (0.76–0.83) |
| 1 T2DM complication | 341 (37) | 35 | 11 | 22 | 61 | 31 | 0.79 (0.76–0.81) |
| 2 or more T2DM complications | 119 (13) | 48 | 12 | 29 | 58 | 37 | 0.74 (0.69–0.80) |
| Blood glucose level | |||||||
| Random blood glucose | 147 (16)# | ||||||
| ≤ 200 mg/dl | 73 (8) | 23 | 9 | 20 | 37 | 22 | 0.70 (0.62–0.76) |
| > 200 mg/dl | 74 (8) | 26 | 12 | 23 | 36 | 27 | 0.63 (0.54–0.71) |
| Fasting blood glucose | 685 (76)# | ||||||
| ≤ 126 mg/dl | 265 (30) | 15 | 4 | 8 | 23 | 10* | 0.79 (0.75–0.82) |
| > 126 mg/dl | 420 (46) | 24 | 9 | 15 | 40 | 21 | 0.75 (0.72–0.78) |
| Postprandial blood glucose | 570 (63)# | ||||||
| ≤ 200 mg/dl | 309 (34) | 18* | 4* | 10* | 32 | 15 | 0.81 (0.78–0.84)* |
| > 200 mg/dl | 261 (29) | 19 | 6 | 12 | 29 | 15 | 0.76 (0.73–0.79) |
#Reporting rate: p value: Chi square; *p value < 0.05; **p value < 0.01
a11% of respondents did not know the duration of their T2DM
bFive participants reported that the reason for not taking metformin was the occurrence of side effects such as dizziness and nausea. Besides that, five participants with normal blood sugar levels but abnormal blood pressure levels requested that they only be given antihypertensive medication because they felt scared if they had to take more than three pills at a time
cComorbidities were defined as diseases other than T2DM complications, such as cancer, tuberculosis, gastritis, low back pain, urinary tract infections, and tumors
Fig. 1Mean (95% CI) EQ-5D index score according to socio-demographic characteristics and clinical condition in Indonesian T2DM outpatients using the Indonesian EQ-5D-5L tariff
Association between socio-demographic characteristics, clinical condition and EQ-5D index scores using a multivariate ordinal regression model
| Variables | Coefficient (95% CI) | |
|---|---|---|
| Socio-demographic characteristics | ||
| From Sulawesi (vs from Java) | 0.88 (0.68–1.14) | 0.344 |
| Secondary care (vs primary care) | 0.32 (0.23–0.48) | < 0.001 |
| Age | 0.79 (0.60–1.05) | 0.113 |
| University degree (vs high school) | 1.83 (1.33–2.53) | < 0.001 |
| With caregiver (vs no caregiver) | 0.65 (0.51–0.84) | < 0.001 |
| Retired (vs active employee) | 0.86 (0.61–1.21) | 0.382 |
| Housewife (vs active employee) | 0.62 (0.42–0.91) | 0.014 |
| Female (vs male) | 0.96 (0.62–1.50) [quintile 1 and 2] | 0.886 |
| 0.96 (0.66–1.42) [quintile 2 and 3] | 0.858 | |
| 1.44 (0.98–2.11) [quintile 3 to 5] | 0.064 | |
| Clinical condition (vs no complications/comorbidities) | ||
| One complication | 1.09 (0.80–1.48) | 0.585 |
| Two or more complications | 0.74 (0.49–1.11) | 0.142 |
| Comorbidities | 0.73 (0.46–1.17) | 0.196 |
| Complications and comorbidities | 0.71 (0.45–1.12) | 0.137 |
| Oral antidiabetic (vs none) | 2.18 (1.22–3.89) | 0.008 |
| Insulin (vs none) | 1.55 (0.86–2.82) | 0.147 |
| Fasting blood glucosea ( | 0.99 (0.99–1.00) | 0.397 |
| Postprandial blood glucosea ( | 0.99 (0.99–1.00) | 0.074 |
| T2DM duration | 1.00 (0.98–1.03) [quintile 1 and 2] | 730 |
| 0.99 (0.97–1.01) [quintile 2 and 3] | 0.505 | |
| 0.98 (0.96–1.01) [quintile 3 to 5] | 0.132 |
EQ-5D index score: 1st quintile (− 0.87 to 0.62), 2nd quintile (0.62–0.80), 3rd quintile (0.80–0.91), 4th quintile (0.91–1), 5th quintile 1
aContinuous variable in the multivariate model
bReporting rate
| Characteristics | |||
|---|---|---|---|
| Arifin et al. (The present study) | Perwitasari et al. [ | Restinia et al. [ | |
| HRQoL instrument | EQ-5D-5L (Indonesia value set) | EQ-5D-3L (Thailand value set) | DQLCTQ |
| EQ-5D index score (95% CI) | 0.77 (95% CI 0.75–0.79) | 0.75 (SD 0.22) | NA |
| Overall study participants | 907 (100) | 86 (100) | 83 (100) |
| Socio-demographic characteristics | |||
| Number of study sites | 8 | 1 | 1 |
| Location | Java and Sulawesi | Singkawang, West Kalimantan | Jakarta |
| Sex | |||
| Male | 387 (43) | 37 (43) | 31 (37) |
| Female | 520 (57) | 49 (57) | 52 (63) |
| Mean age | 59.3 (SD 9.7) | 58.2 (SD 7.8) | > 50 years |
| Age | 886 (98) | 86 (100) | 83 (100) |
| Productive age (< 56 years) | 289 (32) | NR | 3 (4) |
| Retirement age (≥ 56 years) | 597 (66) | NR | 80 (96) |
| Occupation | |||
| Active employment | 314 (35) | 53 (62) | 3 (4) |
| Unemployed | 234 (26) | 33 (38) | 80 (96) |
| Housewife | 359 (39) | NR | NR |
| Education | |||
| Up to senior high school | 698 (77) | 31 (36) | 35 (42) |
| University degree | 209 (23) | 55 (64) | 48 (58) |
| Level of health facilities | |||
| Primary care | 133 (15) | 0 (0) | 0 (0) |
| Secondary care | 774 (85) | 86 (100) | 83 (100) |
| Dependence on a caregiver | |||
| Yes | 488 (54) | NR | NR |
| No | 419 (46) | NR | NR |
| Monthly income (1 USD$ = IDR 14.835) | NR | < 2.2 million ($148): 30 (35) | < 3 million ($202): 47 (57) |
| NR | >2.2 million: 56 (65) | > 3 million: 36 (43) | |
| Family history of T2DM (yes) | NR | 53 (62) | NR |
| Marital status (married) | NR | 76 (88) | NR |
| Clinical condition | |||
| T2DM durationa | 805 (89) | Mean 6.7 (SD 4.9) | NR |
| Less than 5 years | 446 (49) | NR | 14 (17) |
| More than 5 years | 359 (40) | NR | 69 (83) |
| Therapy | |||
| None (diet, herbal or exercise) | 49 (5) | 0 (0) | NR |
| OAD (mono and combinations) | 490 (55) | 78 (91) | NR |
| Insulin (mono and combination with OAD) | 368 (40) | 8 (9) | NR |
| NR | |||
| Types of complications and comorbidities | |||
| Complications | |||
| None | 269 (30) | 0 (0) | NR |
| Macrovascular | 290 (32) | 49 (57) | NR |
| Microvascular | 140 (15) | 12 (14) | NR |
| Macro and microvascular | 30 (3) | 25 (29) | NR |
| Comorbidities | 86 (10) | NR | NR |
| Comorbidities + T2DM complication(s) | 92 (10) | NR | NR |
| Number of T2DM complications | |||
| None | 269 (30) | NR | NR |
| 1 T2DM complication | 341 (37) | NR | NR |
| 2 or more T2DM complications | 119 (13) | NR | NR |
| Blood glucose level | |||
| Random blood glucosea | 147 (16) | NR | NR |
| < 200 mg/dl | 73 (8) | NR | |
| > 200 mg/dl | 74 (8) | NR | |
| Fasting blood glucosea | 685 (76) | Mean 159 (SD 70) | NR |
| < 126 mg/dl | 265 (30) | NR | |
| > 126 mg/dl | 420 (46) | NR | |
| Post prandial blood glucosea | 570 (63) | Mean 245 (SD 90) | NR |
| < 200 mg/dl | 309 (34) | NR | |
| > 200 mg/dl | 261 (29) | NR | |
NR not reported, NA not available, DQLCTQ Diabetes Quality of Life Clinical Trial Questionnaire
aReporting rate